Larvol Delta - Phase-1b-Study-Of-TRICKNK-In-Combination-With-TDxd-In-TreatmentRefractory-Breast-Cancers

rimiducid (AP1903) - Bellicum

Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT07553390

Apr 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next